相关实验视频

Updated: May 5, 2026

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Performing Behavioral Tasks in Subjects with Intracranial Electrodes

Published on: October 2, 2014

临床实践中的静脉输入帕曼尼尔:一个多中心前性注册表研究

Yoshiki Sato¹, Kenichiro Iwami¹, Eriko Okumura¹

¹Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

|August 13, 2025

概括

静脉注射佩拉曼内尔 (IV-PER) 在现实环境中,在7天内有效抑制了89%的患者的发作. 这项研究证实了IV-PER的存在.

科学领域:

神经学神经学
临床药理学临床药理学
发病学 (Epileptology) 是一个专业的学科.

背景情况:

发作需要有效的急性管理.
静脉注射抗药物对于快速控制发作至关重要.
佩拉曼奈尔已在慢性中显示出有效性,但其急性使用需要评估.

研究的目的:

在常规临床实践中评估静脉注射佩拉曼内尔 (IV-PER) 的疗效和安全性.
为了确定IV-PER启动后7天内抑制率.
在急性情况下评估与IV-PER相关的不良事件.

主要方法:

一项前性注册研究包括22所机构的237名接受IV-PER的患者.
患者根据病因分类:脑血管疾病 (CD),脑瘤 (BT) 和创伤性脑损伤 (TBI).
主要终点:7天内抑制率;次要终点:不良事件 (AE).

主要成果:

在7天内整体抑制率为89.0%.
抑制率因病因而有所不同: 87.8% (CD),96.6% (BT),72.3% (TBI).
常见的副作用包括昏昏欲睡和易怒;在71名患者中还发现了实验室异常.

结论:

静脉注射佩拉曼内尔 (IV-PER) 在急性阶段在管理方面表现出显著的疗效.
在现实世界的临床环境中,IV-PER是一种安全的治疗选择,用于各种病因.
这项研究支持IV-PER用于住院患者的急性控制.

关键词:

不良事件是不良事件.有效性有效性.静脉内输入静脉内输入佩拉曼尼尔是一种制剂.安全的安全的安全的安全的安全.抑制发作可以抑制发作.

更多相关视频

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

相关概念视频

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...